Skip to main content

Table 1 Characteristics of the samples analyzed in the study

From: Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy

Telethon Bank ID Experiment ID Karyotype Age (gw) PMI (h) Heart defects GEO accession
NH GROUP       
TB 26 H1 46,XY 20 3 NO GSM30867
TB 21 H2 46,XY 21 3 NO GSM30868
TB 30 H3 46,XY 20 1 NO GSM30869
TB 32 H4 46,XX 21 1 NO GSM30870
TB 23 H5 46,XX 21 4 NO GSM30871
DSH GROUP       
TB 37 DH1 47,XY,+21 21 2 NO GSM30862
TB 43 DH3 47,XY,+21 20 3 NO GSM30863
TB 50 DH4 47,XY,+21 20 3 NO GSM30864
TB 47 DH5 47,XY,+21 19 4 NO GSM30865
TB 48 DH6 47,XY,+21 21 3 NO GSM30866
TB 9 CDH1 47,XY,+21 22 2 YES GSM30723
TB 33 CDH2 47,XY,+21 20 4 YES GSM30855
TB 55 CDH4 47,XX,+21 21 2 YES GSM30864
TB 22 CDH5 47,XX,+21 18 3 YES GSM30859
TB 57 CDH6 47,XX,+21 20 3 YES GSM30860
  1. Experiment accession is GSE1789
  2. DSH = Heart samples from fetuses with trisomy of Hsa21
  3. NH = Heart samples from control fetuses
  4. ID = identifier numbers
  5. gw = gestational weeks
  6. PMI(h) = Post-mortem interval (hours)
  7. Heart defects: TB9, Fallot's trilogy; TB33, Ventricular Septal Defect; TB55 Atrio-Ventricular Canal Defect; TB22 and TB57, Fallot's Tetralogy.
  8. GEO = Gene Expression Omnibus